Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.
Public ClinicalTrials.gov record NCT00708175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Pioglitazone Compared to Placebo on Bone Metabolism in Impaired Fasting Glucose, Postmenopausal Women for One Year of Treatment
Study identification
- NCT ID
- NCT00708175
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- Pioglitazone Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 70 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Dec 31, 2010
- Completion
- Jan 31, 2011
- Last update posted
- Feb 2, 2012
2008 – 2011
United States locations
- U.S. sites
- 34
- U.S. states
- 22
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Greenbrae | California | — | — |
| Not listed | Los Banos | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | West Hills | California | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Longmont | Colorado | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Dunwoody | Georgia | — | — |
| Not listed | Gainesville | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Idaho Falls | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Des Moines | Iowa | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Metarie | Louisiana | — | — |
| Not listed | Scarborough | Maine | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Mineola | New York | — | — |
| Not listed | West Haverstraw | New York | — | — |
| Not listed | Pinehurst | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Aiken | South Carolina | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Brentwood | Tennessee | — | — |
| Not listed | Denton | Texas | — | — |
| Not listed | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00708175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00708175 live on ClinicalTrials.gov.